Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

PSivida's eye disease drug submitted to FDA

June 29, 2010 10:39 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Watertown-based biotechnology company pSivida Corp. has announced that its diabetic macular edema drug product, Iluvien, has been submitted to the U.S. FDA under a new drug application by licensee Alimera Sciences Inc.

Karolinska Development to Divest Portfolio Company

June 29, 2010 10:38 am | by Bio-Medicine.Org | News | Comments

STOCKHOLM , June 29, 2010 /- Today, Karolinska Development has divested Cogmed, one of Karolinska Development's portfolio companies, to Pearson where it will become part of Pearson's Clinical Assessment business. Karolinska Development and other owners will receive an up front payment, as...

TOPICS:

NACDS, NCPA Back Senate Medication Therapy Management Bill

June 29, 2010 10:38 am | by Bio-Medicine.Org | News | Comments

Senator Hagan's legislation would help pharmacists help patients, prevent more costly forms of care ALEXANDRIA, Va. , June 29 /PRNewswire-USNewswire/ -- Building on the passage of pharmacy-specific provisions in the new healthcare reform law, the National Association of Chain Drug Stores...

TOPICS:
Advertisement

Dr. Harry J. Guttman, Esq. Invited Speaker at 2010 Central Regional Meeting of the American Chemical Society

June 29, 2010 10:38 am | by Bio-Medicine.Org | News | Comments

DAYTON and CINCINNATI, Ohio , June 29 /- Dr. Harry J. Guttman, Esq. , Of Counsel Attorney with Stipkala LLC, was an invited speaker and panel discussion participant at the 2010 Central Regional Meeting of the American Chemical Society (CeRMACS) held in Dayton, Ohio June 16-19, 2010 ....

TOPICS:

Millennium Pharmacy Expands in New Jersey

June 29, 2010 10:38 am | by Bio-Medicine.Org | News | Comments

CHICAGO , June 29 /- Hamilton Park Health Care Facility, a skilled nursing facility in Jersey City, New Jersey , has contracted with Millennium Pharmacy Systems for pharmacy services to both their Skilled Nursing and Assisted Living residents. Traditional pharmacy services in the nursing...

TOPICS:

BIO Announces Livestock Biotech Summit Preliminary Program

June 29, 2010 10:37 am | by Biotechnology Industry Organization | News | Comments

WASHINGTON, D.C. (Tuesday, June 29, 2010) - The Biotechnology Industry Organization (BIO) today announces the preliminary program for the 2010 Livestock Biotech Summit which will provide participants three days of cross-cutting discussions among industry, academic and government leaders....

TOPICS:

Award-Winning Thermal Angel Selected as Winner for 'Outstanding Military Product of the Year'

June 29, 2010 10:37 am | by Bio-Medicine.Org | News | Comments

DALLAS , June 29 /PRNewswire-USNewswire/ -- The Thermal Angel Blood and IV Fluid Infusion Warmer , a patented medical device being utilized by U.S. hospitals , military and emergency responders around the globe to lessen the effects of fluid-induced hypothermia, was named the winner for...

TOPICS:

Dehaier Medical Systems Chief Executive Officer To Ring NASDAQ Stock Market Closing Bell

June 29, 2010 10:36 am | by Bio-Medicine.Org | News | Comments

BEIJING , June 29 /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (Nasdaq: DHRM ), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China , today announced members of its Executive Management will ring the...

TOPICS:
Advertisement

Study finds no link between diabetes drug rosiglitazone and increased rate of heart attack

June 29, 2010 7:38 am | by EurekAlert | News | Comments

(Washington University School of Medicine) The diabetes drug rosiglitazone has been under intense scrutiny since a 2007 study linked the drug's use with increased risk of heart attack and death from heart disease. Now, in a post-trial analysis of results from an international...

TOPICS:

Ovarian transplantation restores fertility to old mice and also lengthens their lives

June 29, 2010 7:38 am | by EurekAlert | News | Comments

(European Society of Human Reproduction and Embryology) Scientists have discovered that when they transplant ovaries from young mice into aging female mice, not only does the procedure make the mice fertile again, but also it rejuvenates their behavior and increases their lifespan.

TOPICS:

New data for Vimpat (lacosamide) C-V showed sustained efficacy for up to 5 years

June 29, 2010 7:38 am | by EurekAlert | News | Comments

(Cooney Waters Group, Inc.) New long term data showed that Vimpat (lacosamide) C-V provided sustained reduction in seizure frequency for up to five years when used as an add-on treatment for uncontrolled partial onset seizures in adults with epilepsy.

TOPICS:

InvenSense files registration statement for proposed initial public offering

June 29, 2010 7:37 am | by I-Micronews | News | Comments

InvenSense, Inc., a leading provider of intelligent motion processing solutions that enable a motion-based user interface for consumer electronics, today announced that it has filed a registration statement on Form S-1 with the United States Securities and Exchange Commission for the...

Bind Biosciences takes $12.4M, hires Schnipper

June 29, 2010 7:37 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Cambridge nanoparticle-based drug developer Bind Biosciences Inc. has taken in $12.4 million in a Series C-1 funding round. The company also announced that it has hired Ed Schnipper as chief medical officer.

Accuray Appoints Peter Fine to Board of Directors

June 29, 2010 7:36 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif. , June 29 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today the appointment of Peter Fine as a member of the company's Board of Directors effective June 28, 2010 . Fine will replace board member Li Yu who has resigned...

TOPICS:

Vermillion Announces Issuance of Patent for Alzheimer's Disease Diagnosis

June 29, 2010 7:36 am | by Bio-Medicine.Org | News | Comments

FREMONT, Calif. , June 29 /- Vermillion, Inc. (Pink Sheets: VRML), a molecular diagnostics company, today announced that the United States Patent and Trademark Office (USPTO) has issued a notice of allowance of a patent entitled "Biomarkers for Alzheimer's disease" to the Company. The...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading